$INSY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Insys Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Insys Therapeutics, Inc.. Get notifications about new insider transactions in Insys Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | P | 12.21 | 8,000 | 97,680 | 52,083 | 44.1 K to 52.1 K (+18.15 %) |
May 16 2017 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Buy | P | 11.98 | 4,500 | 53,932 | 4,500 | 0 to 4.5 K |
May 09 2017 | INSY | Insys Therapeutics ... | Vishnoi Rohit | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 09 2017 | INSY | Insys Therapeutics ... | Vishnoi Rohit | Director | Option Exercise | A | 10.68 | 24,000 | 256,320 | 24,000 | |
Apr 20 2017 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Option Exercise | A | 0.00 | 33,000 | 0 | 33,000 | |
Apr 20 2017 | INSY | Insys Therapeutics ... | Motahari Saeed | President & CEO | Option Exercise | A | 10.57 | 325,000 | 3,435,250 | 325,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO and CMO | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO and CMO | Option Exercise | A | 12.65 | 56,000 | 708,400 | 56,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Option Exercise | A | 12.65 | 56,000 | 708,400 | 56,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | KAPOOR JOHN N | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | KAPOOR JOHN N | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | LAPALME PIERRE | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | LAPALME PIERRE | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 12.65 | 16,000 | 202,400 | 16,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Option Exercise | A | 12.65 | 56,000 | 708,400 | 56,000 | |
Jan 17 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO | Option Exercise | A | 10.39 | 30,000 | 311,700 | 30,000 | |
Nov 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | P | 10.75 | 10,000 | 107,489 | 44,083 | 34.1 K to 44.1 K (+29.34 %) |
Sep 01 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 6,000 | |
Sep 01 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 34,083 | 33.6 K to 34.1 K (+1.49 %) |
Aug 16 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 5.96 | 15,000 | 89,400 | 15,000 | |
Aug 16 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 18.02 | 15,000 | 270,300 | 2,000 | 17 K to 2 K (-88.24 %) |
Aug 16 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 5.96 | 15,000 | 89,400 | 17,000 | 2 K to 17 K (+750.00 %) |
Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
Aug 12 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.46 | 15,000 | 276,900 | 49,682 | 64.7 K to 49.7 K (-23.19 %) |
Aug 12 2016 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 18.57 | 5,700 | 105,853 | 42,430,310 | 42.4 M to 42.4 M (+0.01 %) |
Aug 12 2016 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 18.57 | 5,700 | 105,853 | 42,430,310 | 42.4 M to 42.4 M (+0.01 %) |
Aug 09 2016 | INSY | Insys Therapeutics ... | BRENNAN DANIEL | Exec VP & Chf Opera ... | Sell | S | 19.16 | 5,781 | 110,752 | 1 | 5.8 K to 1 (-99.98 %) |
Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 6,500 | |
Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 694 | 10,021 | 22,917 | |
Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 33,583 | 33.1 K to 33.6 K (+1.51 %) |
Aug 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 694 | 10,021 | 33,083 | 32.4 K to 33.1 K (+2.14 %) |
Jul 06 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 695 | 10,036 | 23,611 | |
Jul 06 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 695 | 10,036 | 32,389 | 31.7 K to 32.4 K (+2.19 %) |
Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 14.44 | 694 | 10,021 | 24,306 | |
Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 7,000 | |
Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 14.44 | 694 | 10,021 | 31,694 | 31 K to 31.7 K (+2.24 %) |
Jun 07 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 31,000 | 30.5 K to 31 K (+1.64 %) |
Jun 06 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 3.63 | 16,000 | 58,080 | 0 | |
Jun 06 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 16.27 | 16,000 | 260,320 | 2,000 | 18 K to 2 K (-88.89 %) |
Jun 06 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 3.63 | 16,000 | 58,080 | 18,000 | 2 K to 18 K (+800.00 %) |
May 23 2016 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Option Exercise | M | 13.57 | 10,000 | 135,700 | 80,000 | |
May 23 2016 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Buy | M | 13.57 | 10,000 | 135,700 | 21,030 | 11 K to 21 K (+90.66 %) |
May 18 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 500 | 6,785 | 7,500 | |
May 18 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 500 | 6,785 | 30,500 | 30 K to 30.5 K (+1.67 %) |
May 12 2016 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 12.41 | 10,000 | 124,119 | 42,424,610 | 42.4 M to 42.4 M (+0.02 %) |
May 12 2016 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 12.94 | 40,000 | 517,708 | 42,414,610 | 42.4 M to 42.4 M (+0.09 %) |
May 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | LAPALME PIERRE | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | A | 14.44 | 25,000 | 361,000 | 25,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Option Exercise | A | 14.44 | 40,000 | 577,600 | 40,000 | |
May 04 2016 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Option Exercise | A | 14.44 | 40,000 | 577,600 | 40,000 | |
Mar 04 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 3.63 | 20,000 | 72,600 | 16,000 | |
Mar 04 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 18.11 | 20,000 | 362,200 | 2,000 | 22 K to 2 K (-90.91 %) |
Mar 04 2016 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 3.63 | 20,000 | 72,600 | 22,000 | 2 K to 22 K (+1,000.00 %) |
Mar 04 2016 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 18.22 | 15,000 | 273,300 | 64,682 | 79.7 K to 64.7 K (-18.82 %) |
Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.63 | 9,500 | 34,485 | 50,500 | |
Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 8,500 | 115,345 | 9,500 | |
Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.63 | 9,500 | 34,485 | 18,000 | 8.5 K to 18 K (+111.76 %) |
Feb 09 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 8,500 | 115,345 | 8,500 | 0 to 8.5 K |
Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.63 | 10,500 | 38,115 | 40,000 | |
Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 13.57 | 1,500 | 20,355 | 8,000 | |
Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.63 | 10,500 | 38,115 | 30,000 | 19.5 K to 30 K (+53.85 %) |
Apr 14 2016 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 13.57 | 1,500 | 20,355 | 19,500 | 18 K to 19.5 K (+8.33 %) |
Nov 18 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 30.17 | 750 | 22,628 | 42,374,610 | 42.4 M to 42.4 M (0.00 %) |
Nov 18 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 29.38 | 4,250 | 124,865 | 42,373,860 | 42.4 M to 42.4 M (+0.01 %) |
Nov 16 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 27.29 | 3,000 | 81,870 | 42,369,610 | 42.4 M to 42.4 M (+0.01 %) |
Nov 16 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 26.58 | 5,500 | 146,190 | 42,366,610 | 42.4 M to 42.4 M (+0.01 %) |
Nov 16 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 25.18 | 1,500 | 37,770 | 42,361,110 | 42.4 M to 42.4 M (0.00 %) |
Nov 13 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 26.48 | 30,000 | 794,400 | 79,682 | 109.7 K to 79.7 K (-27.35 %) |
Nov 13 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 26.15 | 900 | 23,535 | 42,359,610 | 42.4 M to 42.4 M (0.00 %) |
Nov 13 2015 | INSY | Insys Therapeutics ... | JOHN N KAPOOR TRUST DATED SEPT ... | 10% Owner | Buy | P | 25.46 | 9,100 | 231,686 | 42,358,710 | 42.3 M to 42.4 M (+0.02 %) |
Sep 22 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 1.62 | 16,068 | 26,030 | 70,000 | |
Sep 22 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 1.62 | 16,068 | 26,030 | 421,572 | 405.5 K to 421.6 K (+3.96 %) |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 3.63 | 2,000 | 7,260 | 36,000 | |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 3.63 | 2,000 | 7,260 | 38,000 | |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 38.08 | 2,000 | 76,160 | 2,000 | 4 K to 2 K (-50.00 %) |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 3.63 | 2,000 | 7,260 | 4,000 | 2 K to 4 K (+100.00 %) |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 36.01 | 700 | 25,207 | 2,000 | 2.7 K to 2 K (-25.93 %) |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 36.00 | 1,300 | 46,800 | 2,700 | 4 K to 2.7 K (-32.50 %) |
Sep 14 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 3.63 | 2,000 | 7,260 | 4,000 | 2 K to 4 K (+100.00 %) |
Jun 10 2015 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Option Exercise | M | 13.27 | 10,000 | 132,700 | 50,000 | |
Jun 10 2015 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Sell | S | 34.48 | 10,000 | 344,800 | 0 | 10 K to 0 (-100.00 %) |
Jun 10 2015 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Buy | M | 13.27 | 10,000 | 132,700 | 10,000 | 0 to 10 K |
Jun 05 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 63.00 | 5,000 | 315,000 | 0 | 5 K to 0 (-100.00 %) |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | M | 1.22 | 3,100 | 3,782 | 16,827 | |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | M | 1.22 | 1,800 | 2,196 | 19,927 | |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Sell | S | 60.09 | 3,100 | 186,279 | 0 | 3.1 K to 0 (-100.00 %) |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Buy | M | 1.22 | 3,100 | 3,782 | 3,100 | 0 to 3.1 K |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Sell | S | 60.00 | 1,800 | 108,000 | 0 | 1.8 K to 0 (-100.00 %) |
May 27 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Buy | M | 1.22 | 1,800 | 2,196 | 1,800 | 0 to 1.8 K |
May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.14 | 1,311 | 78,844 | 54,841 | 56.2 K to 54.8 K (-2.33 %) |
May 27 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 4,784 | 287,040 | 56,152 | 60.9 K to 56.2 K (-7.85 %) |
May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 6,095 | 365,700 | 60,936 | 67 K to 60.9 K (-9.09 %) |
May 20 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 60.00 | 2,969 | 178,140 | 67,031 | 70 K to 67 K (-4.24 %) |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | M | 1.22 | 3,900 | 4,758 | 21,727 | |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | M | 1.22 | 1,200 | 1,464 | 25,627 | |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Sell | S | 60.14 | 3,900 | 234,546 | 0 | 3.9 K to 0 (-100.00 %) |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Buy | M | 1.22 | 3,900 | 4,758 | 3,900 | 0 to 3.9 K |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Sell | S | 60.01 | 1,200 | 72,012 | 0 | 1.2 K to 0 (-100.00 %) |
May 20 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Buy | M | 1.22 | 1,200 | 1,464 | 1,200 | 0 to 1.2 K |
May 18 2015 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Sell | S | 58.83 | 4,000 | 235,320 | 9,377 | 13.4 K to 9.4 K (-29.90 %) |
May 18 2015 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Sell | S | 59.40 | 6,000 | 356,400 | 13,377 | 19.4 K to 13.4 K (-30.96 %) |
May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | M | 3.25 | 18,000 | 58,500 | 16,425 | |
May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 56.29 | 1,600 | 90,064 | 5,000 | 6.6 K to 5 K (-24.24 %) |
May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Sell | S | 57.14 | 16,400 | 937,096 | 6,600 | 23 K to 6.6 K (-71.30 %) |
May 11 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Buy | M | 3.25 | 18,000 | 58,500 | 23,000 | 5 K to 23 K (+360.00 %) |
May 07 2015 | INSY | Insys Therapeutics ... | Tambi Brian | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | LAPALME PIERRE | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | KAPOOR JOHN N | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | MEYER STEVEN J | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | A | 53.50 | 9,000 | 481,500 | 9,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | Del Fosse Franc | General Counsel | Option Exercise | A | 53.50 | 25,000 | 1,337,500 | 25,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | BAKER DARRYL S | Chief Financial Off ... | Option Exercise | A | 53.50 | 25,000 | 1,337,500 | 25,000 | |
May 07 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | A | 53.50 | 60,000 | 3,210,000 | 60,000 | |
Mar 20 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 3.25 | 5,000 | 16,250 | 38,034 | |
Mar 20 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 3.25 | 5,000 | 16,250 | 207,752 | 202.8 K to 207.8 K (+2.47 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 7.26 | 27,400 | 198,924 | 345,755 | |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 7.26 | 1,845 | 13,395 | 373,155 | |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 2.36 | 45,755 | 107,982 | 117,995 | |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Option Exercise | M | 3.25 | 30,000 | 97,500 | 43,034 | |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 58.95 | 1,600 | 94,320 | 202,752 | 204.4 K to 202.8 K (-0.78 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 58.12 | 13,300 | 772,996 | 204,352 | 217.7 K to 204.4 K (-6.11 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 57.21 | 12,500 | 715,125 | 217,652 | 230.2 K to 217.7 K (-5.43 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 7.26 | 27,400 | 198,924 | 230,152 | 202.8 K to 230.2 K (+13.51 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 60.62 | 2,330 | 141,245 | 202,752 | 205.1 K to 202.8 K (-1.14 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 59.71 | 13,546 | 808,832 | 205,082 | 218.6 K to 205.1 K (-6.20 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 59.07 | 23,500 | 1,388,145 | 218,628 | 242.1 K to 218.6 K (-9.71 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Sell | S | 57.91 | 8,224 | 476,252 | 242,128 | 250.4 K to 242.1 K (-3.28 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 7.26 | 1,845 | 13,395 | 250,352 | 248.5 K to 250.4 K (+0.74 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 2.36 | 45,755 | 107,982 | 248,507 | 202.8 K to 248.5 K (+22.57 %) |
Mar 18 2015 | INSY | Insys Therapeutics ... | Babich Michael L | President and CEO | Buy | M | 3.25 | 30,000 | 97,500 | 202,752 | 172.8 K to 202.8 K (+17.37 %) |
Mar 12 2015 | INSY | Insys Therapeutics ... | FOURTEAU PATRICK | Director | Sell | S | 59.94 | 10,000 | 599,359 | 70,000 | 80 K to 70 K (-12.50 %) |
Mar 10 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 7.26 | 3,300 | 23,958 | 20,000 | |
Mar 10 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 60.03 | 3,300 | 198,086 | 1,000 | 4.3 K to 1,000 (-76.74 %) |
Mar 10 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 7.26 | 3,300 | 23,958 | 4,300 | 1,000 to 4.3 K (+330.00 %) |
Mar 06 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Option Exercise | M | 7.26 | 6,700 | 48,642 | 23,300 | |
Mar 06 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Sell | S | 60.11 | 6,700 | 402,746 | 1,000 | 7.7 K to 1,000 (-87.01 %) |
Mar 06 2015 | INSY | Insys Therapeutics ... | STANLEY THEODORE H | Director | Buy | M | 7.26 | 6,700 | 48,642 | 7,700 | 1,000 to 7.7 K (+670.00 %) |